実験的な外傷性出血モデルの凝固形成と静血の障害

Marcus Wannberg¹, Iva Pruner², Apostolos Taxiarchis^1,3

¹Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

|February 17, 2026

まとめ

重度の外傷性出血は血液の凝固を阻害し,血栓生成の減少とハイパーフィブリノリシスにつながる. これにより,より多孔的で,より密度の低い線維素凝固が形成され,死亡リスクが増加します.

科学分野:

トラウマと出血の研究
凝固科学凝固科学とは
実験病理学の実験病理学について

背景:

制御不能の出血は,重度のトラウマで予防可能な主要な死因です.
ヘモスタティック障害は,トラウマの管理を大幅に複雑にします.
血栓形成後の出血を理解することは,結果を改善するために重要です.

研究の目的:

重度の外傷性出血の後の血静の可能性を調査するために.
ウサギの出血モデルで結血形成の特徴を分析する.
トラウマ後の凝血病のメカニズムを解明する.

主な方法:

ニュージーランド白ウサギのオスで40%の出血を引き起こした.
カリブレーションされた自動血栓図を用いたトロンビン生成の測定.
フローサイトメトリーによる全血静止ポテンシャル (OHP) とマイクロベシクルの評価.
ファイブリン凝固構造分析のためのスキャニング電子顕微鏡 (SEM).

主要な成果:

トラウマ性出血は血小板数,フィブリノゲンの減少,INRと乳酸の増加を引き起こします.
OHPと全体的な凝固ポテンシャル (OCP) は著しく低下しました.
ハイパーフィブリノリシスが増加し,血小板由来マイクロベシクルとトロンビン生成が減少した.
SEMは,出血後のより薄い繊維を持つ,より多孔性の繊維凝固を明らかにしました.

結論:

トラウマ性出血は,トロンビン生成の減少とハイパーフィブリノリシスによって特徴づけられる凝血病を誘発する.
その結果生じるフィブリン凝固は,多孔性があり,密度が低く,繊維が薄くなります.
これらの発見は,血静と凝固の構造に関する洞察を提供し,外傷性出血に対する潜在的標的治療を告知します.

キーワード:

凝固病 (coagulopathy) とは凝固病 (coagulopathy) とは凝固病 (coagulopathy) とは実験用ウサギモデル出血の出血は,出血によるものです.トラウマ・トラウマトラウマ・トラウマトラウマ・トラウマトラウマ・トラウマ

さらに関連する動画

04:03

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury

Published on: February 21, 2025

1.1K

08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.6K

関連する概念動画

01:20

Extrinsic and Intrinsic Pathways of Hemostasis

13.4K

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

13.4K

01:24

Disorders of Hemostasis

2.3K

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

2.3K

01:05

Introduction to Hemostasis

14.9K

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...

14.9K

01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.0K

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

2.0K

01:22

Formation of the Platelet Plug

9.6K

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

9.6K

01:16

Clot Retraction and Fibrinolysis

9.2K

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.